Polymorphism in the nuclear factor kappa-B binding promoter region of cyclooxygenase-2 is associated with an increased risk of bladder cancer
- 10 January 2005
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 217 (1) , 11-16
- https://doi.org/10.1016/j.canlet.2004.06.053
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Why there are two cyclooxygenase isozymesJournal of Clinical Investigation, 2001
- Regulation of Cyclooxygenase-2 by Interferon γ and Transforming Growth Factor α in Normal Human Epidermal Keratinocytes and Squamous Carcinoma CellsJournal of Biological Chemistry, 1999
- Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer CellsPublished by Elsevier ,1998
- CYCLOOXYGENASES 1 AND 2Annual Review of Pharmacology and Toxicology, 1998
- Interleukin-1 Induces Cyclooxygenase-2 Gene Expression in Cultured Endometrial Stromal CellsJournal of Clinical Endocrinology & Metabolism, 1998
- Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potentialProceedings of the National Academy of Sciences, 1997
- Transcriptional Roles of Nuclear Factor κB and Nuclear Factor-Interleukin-6 in the Tumor Necrosis Factor α-Dependent Induction of Cyclooxygenase-2 in MC3T3-E1 CellsJournal of Biological Chemistry, 1995
- v-src Induces Prostaglandin Synthase 2 Gene Expression by Activation of the c-Jun N-terminal Kinase and the c-Jun Transcription FactorJournal of Biological Chemistry, 1995
- Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2Cell, 1995
- Transcriptional Regulation of Human Prostaglandin-endoperoxide Synthase-2 Gene by Lipopolysaccharide and Phorbol Ester in Vascular Endothelial CellsJournal of Biological Chemistry, 1995